Anondita Medicare Limited receives In-Principle Approval from NSE for Rights Issue
Anondita Medicare Limited has secured the In-Principle Approval from the National Stock Exchange of India Limited (NSE) for a proposed Rights Issue of its fully paid-up equity shares. This approval permits the company to proceed with the issuance and allotment of the equity shares on a rights basis, subject to applicable laws and regulatory requirements.The National Stock Exchange of India Limited granted the In-Principle Approval on August 25, 2026. The proposed Rights Issue involves fully paid-up equity shares, each having a face value of ₹10/-. The issue is aggregated up to ₹10,978.20 lakhs.
The approval signifies that Anondita Medicare Limited is permitted to issue and allot the securities to eligible equity shareholders in the ratio of [●] rights Equity for every [●] equity shares held on the record date.
Key details regarding the approval granted by the NSE are summarized below:
| Particulars | Details |
|---|---|
| Regulatory Authority | National Stock Exchange of India Limited (NSE) |
| Type of Approval | In-Principle approval for issuance of fully paid up equity shares on right basis |
| Impact of Approval | Upon receipt of the approval, the Company is permitted to issue and allot the fully paid-up equity share, having a face value of Rs. 10/ , on a Rights basis, subject to applicable laws and regulatory approvals. |
| Period of Validity | As per the relevant applicable provisions |
The issuance of the equity shares is planned on a rights basis to eligible equity shareholders of the company. This development allows Anondita Medicare Limited to move forward with the capital raising through the planned rights issue.
ANONDITA Stock Price Movement
Shares of Anondita Medicare Limited are trending upward at ₹1064.85 as of 12:43 PM, buoyed by a small rise of 0.01% in live trading. Trading activity shows solid interest as the stock exchanges 7,000 shares during the current market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.